Iterum Therapeutics plc (ITRMF) EBT Margin (2017 - 2025)

Iterum Therapeutics has reported EBT Margin for 4 years, with the latest figure at 2268.46% in Q3 2025.

• On a quarterly basis, EBT Margin changed N/A year-over-year to 2268.46% in Q3 2025; TTM through Sep 2025 was 6937.18%, a N/A change from a year earlier, with the FY2019 full-year figure at 278837.84%, down 27002495.0% from the prior year.
• EBT Margin was 2268.46% for Q3 2025 at Iterum Therapeutics, up from 55259.46% in the prior quarter.
• The five-year high for EBT Margin was 2268.46% in Q3 2025, with the low at 2268.46% in Q3 2025.